FBRX - Forte Biosciences, Inc.
IEX Last Trade
16
-0.760 -4.750%
Share volume: 72,645
Last Updated: Mon 13 Jan 2025 10:00:00 PM CET
Research and Development in Biotechnology (except Nanobiotechnology):
-0.38%
PREVIOUS CLOSE
CHG
CHG%
$16.76
-1.78
-0.10%
View ratios
| Fiscal Date | 2024-03-31 | 2024-06-30 | 2024-09-30 | |
|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | |
| Report Date | 2024-05-13 | 2024-08-14 | 2024-11-14 | |
| Cash flow financing | -8.000 K | -10.000 K | -2.000 K | |
| Other financing cash flows | -16.000 K | -10.000 K | -8.000 K | |
| Cash flow | -6.681 M | 0.000 | 0.000 | |
| Net income | -7.420 M | -12.511 M | -8.392 M | |
| Depreciation | 9.000 K | 10.000 K | 10.000 K | |
| Changes in inventories | 0.000 | 0.000 | 0.000 | |
| Changes in receivables | 0.000 | 0.000 | 0.000 | |
| Investing Cashflow | -6.000 K | 0.000 | 0.000 | |
| Net Borrowings | 0.000 | 0.000 | 0.000 | |
| Investing Activity Other | 0.000 | 0.000 | 0.000 | |
| Dividends Paid | 0.000 | 0.000 | 0.000 | |
| Exchange Rate Effect | 0.000 | 0.000 | 0.000 | |
| Capital Expenditures | 6.000 K | 0.000 | 0.000 | |
| Cash Change | -6.681 M | -5.946 M | -8.135 M |